Suchergebnisse - "Prednisolone"

PubPharm (3.576)

1

A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma

enthalten in: Japanese journal of clinical oncology | 2024

von Saito, T. | Nagai, H. | Izutsu, K. | +7

2

Renal relapse in children and adolescents with childhood-onset lupus nephritis : a 20-year study

enthalten in: Rheumatology (Oxford, England) | 2024

von Chan, E. | Yap, D. | Wong, W. | +12

3

Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma : protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20)

enthalten in: BMJ open | 2024

von Sekimizu, M. | Fukano, R. | Koga, Y. | +14

4

In vitro chemosensitivity testing of the feline large granular lymphocyte cell line (S87)

enthalten in: Veterinary medicine and science | 2024

von Hartung, S. | Herden, C. | Sparenberg, M. | +1

5

Cyclophosphamide Toxicity in Pediatric Nephrotic Syndrome Patient : A Case Report and Literature Review

enthalten in: Current drug safety | 2024

von Patil, S. | Patil, M. | Bagalkotkar, A. | +1

6

Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis : predefined 2-year follow-up study

enthalten in: Annals of the rheumatic diseases | 2024

von Furuta, S. | Nakagomi, D. | Kobayashi, Y. | +17

7

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK) : final results of a multicentre, phase 3, open-label, randomised trial

enthalten in: The Lancet. Haematology | 2023

von Chamuleau, M. | Stenner, F. | Chitu, D. | +28

8

Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma

enthalten in: Indian journal of pharmacology | 2023

von Morabad, S. | Khan, Z. | Gad, R. | +4

9

Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma : A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study

enthalten in: Cancer research and treatment | 2023

von Kim, Y. | Kim, J. | Kim, W. | +18

10

Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas

enthalten in: Leukemia & lymphoma | 2023

von Ribereau-Gayon, E. | Donzel, M. | Pham, F. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[358]